BHST

MKT CAP:$75M

BioHarvest Sciences Inc. Common Stock

Market Cap

$75M

Basic Materials·Agricultural Inputs·🇨🇦 Canada·NASDAQ

Materials·Agricultural·🇨🇦·NASDAQ

Stock Price

$4.38-$0.83 (-15.93%)

Apr 24, 2026

Company Details

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cell...

CEO

Ilan Sobel

IPO Date

Jan 8, 2021

Website

www.bioharvest.com

Key Metrics TTM

Revenue

$35M

+37.0% YoY

Net Income

-$11M

EPS (Diluted)

-$0.63

Free Cash Flow

-$10M

Revenue / Share

$1.87

Gross Margin

59.3%

Operating Margin

-16.2%

Net Margin

-32.3%

FCF Margin

-28.1%

P/S

2.2x

P/E

—

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Mar 31, 2026

$35M+37.0%EPS -$0.60

Q4 2025

Mar 31, 2026

$9M+24.6%EPS -$0.12

Q3 2025

Nov 13, 2025

$9M+38.7%EPS -$0.14

Q2 2025

Aug 11, 2025

$9M+41.3%EPS -$0.24

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$699.0K	$179.0K	-$3M
Q2 22	$838.0K	$100.0K	-$2M
Q3 22	$2M	$274.0K	-$3M
Q4 22	$2M	$666.0K	-$3M
Q1 23	$2M	$792.0K	-$3M
Q2 23	$3M	$1M	-$3M
Q3 23	$3M	$1M	-$2M
Q4 23	$5M	$2M	-$3M
Q1 24	$5M	$3M	-$1M
Q2 24	$6M	$3M	-$2M
Q3 24	$7M	$4M	-$2M
Q4 24	$7M	$4M	-$2M
Q1 25	$8M	$5M	-$2M
Q2 25	$9M	$5M	-$2M
Q3 25	$9M	$6M	-$920.0K
Q4 25	$9M	$5M	-$1M

Valuation

Quarter	P/S	P/E
Q1 22	34.8x	—
Q2 22	29.8x	—
Q3 22	22.9x	—
Q4 22	15.8x	—
Q1 23	12.4x	—
Q2 23	9.8x	—
Q3 23	8.2x	—
Q4 23	6.8x	—
Q1 24	5.5x	—
Q2 24	4.5x	—
Q3 24	3.9x	—
Q4 24	4.1x	—
Q1 25	3.9x	—
Q2 25	3.9x	—
Q3 25	5.3x	—
Q4 25	2.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$3M	-$3M
Q2 22	-$2M	-$2M
Q3 22	-$2M	-$3M
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q2 23	-$3M	-$3M
Q3 23	-$995.0K	-$1M
Q4 23	-$3M	-$3M
Q1 24	-$2M	-$2M
Q2 24	-$958.0K	-$3M
Q3 24	-$2M	-$2M
Q4 24	-$3M	-$3M
Q1 25	-$1M	-$2M
Q2 25	-$2M	-$2M
Q3 25	-$2M	-$3M
Q4 25	-$2M	-$3M

Capital Expenditures

Quarter	CapEx
Q1 22	$391.0K
Q2 22	$323.0K
Q3 22	$279.0K
Q4 22	$229.0K
Q1 23	$376.0K
Q2 23	$367.0K
Q3 23	$440.0K
Q4 23	$272.7K
Q1 24	$222.0K
Q2 24	$2M
Q3 24	$512.0K
Q4 24	$344.8K
Q1 25	$684.0K
Q2 25	$615.3K
Q3 25	$427.6K
Q4 25	$654.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+123.3%	+30.9%
Q2 22	+101.9%	+17.7%
Q3 22	+135.6%	+35.1%
Q4 22	+234.8%	+160.2%
Q1 23	+209.4%	+41.0%
Q2 23	+228.2%	+70.3%
Q3 23	+113.5%	+16.7%
Q4 23	+84.9%	+41.9%
Q1 24	+147.1%	+44.1%
Q2 24	+119.2%	+38.7%
Q3 24	+101.9%	+64.7%
Q4 24	+61.0%	+26.8%
Q1 25	+47.1%	+41.5%
Q2 25	+41.3%	+32.4%
Q3 25	+38.7%	+15.6%
Q4 25	+24.6%	+13.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$473.0K	67.7%
Q2 22	$195.0K	23.3%
Q3 22	$339.0K	22.3%
Q4 22	$0	0.0%
Q1 23	$124.0K	5.7%
Q2 23	$189.0K	6.9%
Q3 23	$118.0K	3.6%
Q4 23	$0	0.0%
Q1 24	$133.0K	2.5%
Q2 24	$195.0K	3.2%
Q3 24	$126.0K	1.9%
Q4 24	$0	0.0%
Q1 25	$132.0K	1.7%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$148.0K	1.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$771.0K	$1M	$1M	—
Q2 22	$415.0K	$1M	$1M	—
Q3 22	$554.0K	$1M	$2M	—
Q4 22	$568.0K	$2M	$598.0K	—
Q1 23	$611.0K	$875.0K	$2M	—
Q2 23	$812.0K	$1M	$2M	—
Q3 23	$894.0K	$757.0K	$2M	—
Q4 23	$1M	$3M	$906.0K	—
Q1 24	$1M	$829.0K	$3M	—
Q2 24	$1M	$978.0K	$3M	—
Q3 24	$1M	$1M	$3M	—
Q4 24	$1M	$4M	$469.0K	—
Q1 25	$1M	$1M	$4M	—
Q2 25	$1M	$2M	$4M	—
Q3 25	$1M	—	—	$5M
Q4 25	$1M	$2M	$1M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$1M	$0	$1M
Q2 22	$1M	$0	$1M
Q3 22	$2M	$0	$2M
Q4 22	$2M	$0	$2M
Q1 23	$300.0K	$0	$300.0K
Q2 23	$2M	$0	$2M
Q3 23	$2M	$0	$2M
Q4 23	$5M	$0	$5M
Q1 24	$3M	$0	$3M
Q2 24	$5M	$0	$5M
Q3 24	$3M	$0	$3M
Q4 24	$2M	$0	$2M
Q1 25	$3M	$0	$3M
Q2 25	$4M	$0	$4M
Q3 25	$11M	$0	$11M
Q4 25	$23M	$0	$23M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	13M	+4.4%	+7.4%
Q2 22	13M	+0.0%	+5.3%
Q3 22	13M	+0.8%	+5.5%
Q4 22	13M	-0.1%	+5.2%
Q1 23	13M	+1.8%	+2.5%
Q2 23	13M	+0.8%	+3.3%
Q3 23	13M	+0.0%	+2.6%
Q4 23	13M	0.0%	+2.7%
Q1 24	14M	+2.4%	+3.3%
Q2 24	16M	+18.9%	+21.8%
Q3 24	17M	+6.1%	+29.2%
Q4 24	17M	-0.1%	+29.1%
Q1 25	17M	0.0%	+26.1%
Q2 25	17M	+0.0%	+6.0%
Q3 25	17M	+0.6%	+0.5%
Q4 25	18M	+5.7%	+6.3%

Shares Outstanding